(aR)-(3S)-1-{4-[{4-Chloro-2-[(S)-hydroxy(2-methoxyphenyl)methyl]-6-(propan-2-yloxy)phenyl}(2,2-dimethylpropyl)amino]-4-oxobutanoyl}piperidine-3-carboxylic acid

ID: ALA1819577

PubChem CID: 53379397

Max Phase: Preclinical

Molecular Formula: C32H43ClN2O7

Molecular Weight: 603.16

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1[C@@H](O)c1cc(Cl)cc(OC(C)C)c1N(CC(C)(C)C)C(=O)CCC(=O)N1CCC[C@H](C(=O)O)C1

Standard InChI:  InChI=1S/C32H43ClN2O7/c1-20(2)42-26-17-22(33)16-24(30(38)23-11-7-8-12-25(23)41-6)29(26)35(19-32(3,4)5)28(37)14-13-27(36)34-15-9-10-21(18-34)31(39)40/h7-8,11-12,16-17,20-21,30,38H,9-10,13-15,18-19H2,1-6H3,(H,39,40)/t21-,30+/m0/s1

Standard InChI Key:  CLELLBMJLWSCHW-URAOTHONSA-N

Molfile:  

     RDKit          2D

 42 44  0  0  0  0  0  0  0  0999 V2000
   -5.0139  -26.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0151  -27.1273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3003  -27.5402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5838  -27.1269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5867  -26.2963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3021  -25.8872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7285  -25.8876    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.8738  -25.8811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8687  -27.5382    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8674  -28.3632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1549  -27.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1523  -28.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1510  -29.5996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4385  -28.3610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4417  -29.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4398  -27.5360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8769  -25.0561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1562  -26.2996    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1622  -24.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1650  -23.8215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8815  -23.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5968  -23.8306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5905  -24.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4475  -25.0579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7333  -24.6451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1625  -25.4625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7260  -27.1224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0108  -27.5337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7030  -27.1201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0095  -28.3587    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130  -27.5346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1247  -27.1245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1277  -26.2992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4127  -25.8856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6948  -26.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4146  -25.0587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1298  -24.6475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7009  -24.6449    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3005  -28.3652    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0150  -28.7775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7294  -28.3649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0153  -29.6025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 20 21  2  0
  2  3  1  0
 21 22  1  0
  9 11  1  0
 22 23  2  0
 23 17  1  0
  5  6  2  0
 19 24  1  0
 10 12  1  0
 24 25  1  0
  6  1  1  0
  8 26  1  1
 12 13  1  0
 16 27  1  0
  1  2  2  0
 27 28  1  0
 12 14  1  0
 28 29  1  0
  1  7  1  0
 28 30  2  0
 29 31  1  0
 12 15  1  0
  3  4  2  0
 11 16  1  0
  5  8  1  0
  8 17  1  0
 29 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 11 18  2  0
  4  9  1  0
 36 37  1  0
 36 38  2  0
 34 36  1  1
 17 19  2  0
  3 39  1  0
  4  5  1  0
 39 40  1  0
 19 20  1  0
 40 41  1  0
  9 10  1  0
 40 42  1  0
M  END

Associated Targets(Human)

Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Fdft1 Squalene synthetase (891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2621 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Syrian golden hamster (1610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
marmosets (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 603.16Molecular Weight (Monoisotopic): 602.2759AlogP: 5.70#Rotatable Bonds: 11
Polar Surface Area: 116.61Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.95CX Basic pKa: CX LogP: 4.47CX LogD: 1.28
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.34Np Likeness Score: -1.06

References

1. Ichikawa M, Yokomizo A, Itoh M, Haginoya N, Sugita K, Usui H, Terayama K, Kanda A..  (2011)  Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.,  19  (17): [PMID:21802309] [10.1016/j.bmc.2011.07.007]

Source